201 related articles for article (PubMed ID: 18495217)
1. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
[No Abstract] [Full Text] [Related]
2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
3. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
Bailleul E; Van Vaerenbergh K; Lust A
Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
[No Abstract] [Full Text] [Related]
4. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
[TBL] [Abstract][Full Text] [Related]
5. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
Brandt JT; Triplett DA
Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
[TBL] [Abstract][Full Text] [Related]
6. The dilute Russell's viper venom time.
Radhakrishnan K
Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
[TBL] [Abstract][Full Text] [Related]
7. Acquired activated protein C-resistance in patients with lupus anticoagulants.
Ehrenforth S; Radtke KP; Scharrer I
Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
[No Abstract] [Full Text] [Related]
8. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulants.
Shapiro SS; Thiagarajan P
Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
[No Abstract] [Full Text] [Related]
10. Lupus anticoagulants in children.
Singh AK; Rao KP; Kizer J; Lazarchick J
Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
[TBL] [Abstract][Full Text] [Related]
11. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
[TBL] [Abstract][Full Text] [Related]
12. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants.
Reber G; Roisin JP; Migaud M; de Moerloose P
Thromb Res; 1994 Jan; 73(2):131-5. PubMed ID: 8171412
[No Abstract] [Full Text] [Related]
14. Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors.
Ruinemans-Koerts J; Peterse-Stienissen I; Verbruggen B
Thromb Haemost; 2010 Nov; 104(5):1080-2. PubMed ID: 20806127
[No Abstract] [Full Text] [Related]
15. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
Zhang L; Whitis JG; Embry MB; Hollensead SC
Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
[TBL] [Abstract][Full Text] [Related]
16. Monitoring oral anticoagulation in patients with "strong" lupus anticoagulant. Present situation in France.
Goudemand J; Boffa MC
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():36-7. PubMed ID: 8952759
[No Abstract] [Full Text] [Related]
17. Coagulation profile in systemic lupus erythematosus studies in 20 patients.
Boey ML; Tsakok FH; Feng PH
Singapore Med J; 1985; 26(4-5):361-4. PubMed ID: 4071090
[No Abstract] [Full Text] [Related]
18. [The lupus inhibitor].
Carreras LO; Vermylen J
Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
[No Abstract] [Full Text] [Related]
19. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature.
Erkan D; Bateman H; Lockshin MD
Lupus; 1999; 8(7):560-4. PubMed ID: 10483036
[TBL] [Abstract][Full Text] [Related]
20. Prolonged activated partial thromboplastin times and detection of the lupus anticoagulant.
Lucas FV; Miller ML
Arch Pathol Lab Med; 1993 Jun; 117(6):589-90. PubMed ID: 8503727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
